CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
| dc.contributor.author | Schnell, Oliver | |
| dc.contributor.author | Battelino, Tadej | |
| dc.contributor.author | Bergenstal, Richard | |
| dc.contributor.author | Birkenfeld, Andreas L. | |
| dc.contributor.author | Ceriello, Antonio | |
| dc.contributor.author | Cheng, Alice | |
| dc.contributor.author | Davies, Melanie | |
| dc.contributor.author | Edelman, Steve | |
| dc.contributor.author | Forst, Thomas | |
| dc.contributor.author | Giorgino, Francesco | |
| dc.contributor.author | Green, Jennifer | |
| dc.contributor.author | Groop, Per\\-Henrik | |
| dc.contributor.author | Hadjadj, Samy | |
| dc.contributor.author | Heerspink, Hiddo J. L. | |
| dc.contributor.author | Hompesch, Marcus | |
| dc.contributor.author | Izthak, Baruch | |
| dc.contributor.author | Ji, Linong | |
| dc.contributor.author | Kanumilli, Naresh | |
| dc.contributor.author | Mankovsky, Boris | |
| dc.contributor.author | Mathieu, Chantal | |
| dc.contributor.author | Miszon, Martin | |
| dc.contributor.author | Mustafa, Reem | |
| dc.contributor.author | Nauck, Michael | |
| dc.contributor.author | Pecoits\\-Filho, Roberto | |
| dc.contributor.author | Pettus, Jeremy | |
| dc.contributor.author | Ranta, Kari | |
| dc.contributor.author | Rodbard, Helena W. | |
| dc.contributor.author | Rossing, Peter | |
| dc.contributor.author | Ryden, Lars | |
| dc.contributor.author | Schumm\\-Draeger, Petra\\-Maria | |
| dc.contributor.author | Solomon, Scott D. | |
| dc.contributor.author | Skrha, Jan | |
| dc.contributor.author | Topsever, Pinar | |
| dc.contributor.author | Vilsboll, Tina | |
| dc.contributor.author | Wilding, John | |
| dc.contributor.author | Standl, Eberhard | |
| dc.date.accessioned | 2025-10-16T15:15:45Z | |
| dc.date.issued | 2023 | |
| dc.identifier.doi | 10.1186/s12933-023-01788-6 | |
| dc.identifier.other | WOS:000954649400001 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/6529 | |
| dc.publisher | BMC | |
| dc.source | CARDIOVASCULAR DIABETOLOGY | |
| dc.subject | Cardiovascular disease | |
| dc.subject | Chronic kidney disease | |
| dc.subject | Diabetes | |
| dc.subject | GIP | |
| dc.subject | GLP\\-1 receptor agonist | |
| dc.subject | Heart failure | |
| dc.subject | Obesity | |
| dc.subject | SGLT2 inhibitor | |
| dc.title | CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes | |
| dc.type | Editorial Material |
